<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:usg="https://explorer.usaid.gov">
  <iati-identifier>US-GOV-1-7200AA22CA00002</iati-identifier>
  <reporting-org ref="US-GOV-1" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Microbicide 2021 R&amp;D Project: Advancing the Research and Development of Innovative HIV Prevention Products for Women (MATRIX)</narrative>
  </title>
  <description>
   <narrative xml:lang="EN">USAID supports promising HIV prevention products that are in the later stages of development (e.g., those completing safety and efficacy clinical trials). These are products with the potential to reach regulatory approval within five years and incorporate a range of desirable product characteristics identified through end-user research with women (e.g., related to regimen, duration, reduced side effects, discreetness, etc.). Investments in promising products will be prioritized based on expected potential for impact on the HIV epidemic.</narrative>
  </description>
  <participating-org ref="US-GOV-11" role="1" type="10">
   <narrative xml:lang="EN">Department of State</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-61000" role="4" type="22">
   <narrative xml:lang="EN">MAGEE-WOMENS RESEARCH INSTITUTE AND FOUNDATION</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="2" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <participating-org ref="US-GOV-1" role="3" type="10">
   <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2021-11-30" type="1"></activity-date>
  <activity-date iso-date="2021-11-30" type="2"></activity-date>
  <activity-date iso-date="2026-11-30" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">U.S. Agency for International Development</narrative>
   </organisation>
   <person-name>
    <narrative xml:lang="EN"></narrative>
   </person-name>
   <telephone>+1 (202) 712 4810</telephone>
   <email>aidtransparency@usaid.gov</email>
   <website>https://www.usaid.gov/who-we-are/organization/bureaus/bureau-global-health</website>
   <mailing-address>
    <narrative xml:lang="EN">1300 Pennsylvania Ave NW, Washington DC 20004</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="1"></activity-scope>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <transaction ref="C375C594E438">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-11-30"></transaction-date>
   <value currency="USD" value-date="2021-11-30">25000000</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-region code="998"></recipient-region>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2021" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="AC13C5A30997">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">712104.21</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-region code="998"></recipient-region>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2021" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="AC13C5A30997">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-04-30"></transaction-date>
   <value currency="USD" value-date="2022-04-30">712104.21</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-region code="998"></recipient-region>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2021" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <transaction ref="7CB06B0D52A4">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2022-05-31"></transaction-date>
   <value currency="USD" value-date="2022-05-31">982754.64</value>
   <disbursement-channel code="2"></disbursement-channel>
   <sector code="3001" vocabulary="99">
    <narrative xml:lang="EN">HIV/AIDS</narrative>
   </sector>
   <sector code="13040" vocabulary="1">
    <narrative xml:lang="EN">STD control including HIV/AIDS</narrative>
   </sector>
   <recipient-region code="998"></recipient-region>
   <usg:treasury-account>
    <usg:fiscal-funding-year begin="2021" end="2022"></usg:fiscal-funding-year>
    <usg:main-account code="1031">Global Health Programs</usg:main-account>
    <usg:regular-account code="19"></usg:regular-account>
   </usg:treasury-account>
  </transaction>
  <conditions attached="0"></conditions>
  <usg:duns-number>
   <narrative>119132785</narrative>
  </usg:duns-number>
  <usg:mechanism-signing-date iso-date="2021-12-01"></usg:mechanism-signing-date>
  <usg:state-location>
   <narrative>Worldwide</narrative>
  </usg:state-location>
  <usg:tec1>
   <narrative>125000000.00</narrative>
  </usg:tec1>
 </iati-activity>
</iati-activities>
